Add Yahoo as a preferred source to see more of our stories on Google. Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her ...
New York, USA, April 14, 2026 (GLOBE NEWSWIRE)-- The Psoriasis Clinical Trial Pipeline Boom as 90+ Companies are in the Race for Better Treatments | DelveInsight The psoriasis clinical trial analysis ...
Hosted on MSN
Psoriasis treatments can be life-changing
If you suffer from psoriasis, vibrant, clear skin is no longer out of reach. Subscribe to our newsletter for the latest sci-tech news updates. "The idea of clear skin for patients with psoriasis, ...
The Roivant Sciences strategy of finding shelved drug candidates and castoff research from big pharmaceutical companies has paid off. A compound that Roivant acquired from GlaxoSmithKline now has FDA ...
Psoriasis, one of the most common immune-mediated diseases, currently affects more than 7.5 million adults ages 20 and older in the U.S. The cutaneous condition is characterized by the excessive ...
Psoriasis, a chronic autoimmune condition, causes inflammation in the skin, most often leading to thick, scaly areas called plaques. An overactive immune system speeds up skin cell development, ...
Marketing authorisation in Great Britain has been granted for deucravacitinib by the MHRA for use in the treatment of moderate to severe plaque psoriasis in adults. Earlier this year, deucravacitinib ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results